Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
By Dengyuemed International Business Department November 28 — The National Medical Products Administration (NMPA) has approved the marketing of picankibart injection, an innovative IL-23p19–targeting ...
Discover effective solutions for dry skin, eczema, acne scars, and psoriasis in this step-by-step skincare routine with ...
Winter ages your hands — here’s how experts combat dryness, including ‘hand slugging’. Nursem founder and NHS nurse, Antonia ...
Neem fights bad breath, acne, viral infections, and even lowers blood sugar. Here is simple science behind these powerful ...
Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a ...
Financial stability and fostering unity to combat “division and chaos” are two top priorities for new American College of ...
According to MarketsandMarketstm, the clinical chemistry analyzers market is projected to grow from USD 25.92 billion in 2025 to USD 20.86 billion by 2030, at a CAGR of ...
Senator Cynthia Lummis (R-WY) is supposedly a leader on crypto policy. But it's hard to see how that's the case after she fumbled the opportunity to get President Trump's bipartisan signature crypto ...
Investing.com -- UCB SA (EBR:UCB) shares rose more than 3% on Friday after the Belgian biopharmaceutical company lifted its 2025 revenue and margin guidance, citing stronger contributions from several ...
PDE4 Inhibitor Commercial success: ZORYVE achieved $166 million in revenue during 2024, representing a remarkable 471% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback